Skip to main content
OpenTrials
Completed

NCT Number: NCT03643770

Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals With Spinal Cord Injury

Currently, there are a variety of approaches utilized in attempts to improve upper extremity function, including: traditional therapy, neuroprostheses, botulinum toxin injections, or surgical interventions. In addition, regenerative and restorative therapies, such as: epidural stimulation, functional electrical stimulation, and stem cell therapies, show promise in animal models, but are not ready for clinical translation. Subsequently, there is a clear need to develop new strategies that can stimulate spinal plasticity and strengthen existing synaptic connections in order to maximize the benefits of training paradigms.

This study proposes the examine the effects of Acute Intermittent Hypoxia (AIH) in combination with upper extremity training, over the course of a month, to evaluate changes in upper extremity function, dexterity, and ability to complete activities of daily living. The use of acute intermittent hypoxia (AIH) has been demonstrated, through human and animal studies, to be an effective way of increasing spinal motor excitability and strengthening residual synaptic connectivity. AIH utilizes short duration (<2 min) exposures to reduced oxygen levels (~10% inspired oxygen), with alternating exposures to air with normal oxygen levels (~21% inspired oxygen).

Previous publications demonstrate that AIH is a safe and effective intervention to modify motor function in individual with chronic incomplete spinal cord injuries. The use of AIH has been shown to influence the activation in musculature, within 60-120 minutes of administration. In addition, when coupling AIH with overground gait training, an increase in functional endurance, as evaluated through the 6 minute walk test, and gait speed, as evaluated through the 10 meter walk test, were demonstrated. In addition, the use of hypoxic training has been studied in healthy individuals and athletes; however, literature examining the effect of a single bout of AIH on performance is limited.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

About this study

This study proposes the examine the effects of Acute Intermittent Hypoxia (AIH) in combination with upper extremity training, over the course of a month, to evaluate changes in upper extremity function, dexterity, and ability to complete activities of daily living. The use of acute intermittent hypoxia (AIH) has been demonstrated, through human and animal studies, to be an effective way of increasing spinal motor excitability and strengthening residual synaptic connectivity. AIH utilizes short duration (<2 min) exposures to reduced oxygen levels (~10% inspired oxygen), with alternating exposures to air with normal oxygen levels (~21% inspired oxygen).

Previous publications demonstrate that AIH is a safe and effective intervention to modify motor function in individual with chronic incomplete spinal cord injuries. The use of AIH has been shown to influence the activation in musculature, within 60-120 minutes of administration. In addition, when coupling AIH with overground gait training, an increase in functional endurance, as evaluated through the 6 minute walk test, and gait speed, as evaluated through the 10 meter walk test, were demonstrated. In addition, the use of hypoxic training has been studied in healthy individuals and athletes; however, literature examining the effect of a single bout of AIH on performance is limited.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of a non-progressive spinal cord injury, inclusive of levels of C1-T1.
  • Etiology of spinal cord injury is non-progressive in nature
  • Be able to demonstrate some hand muscle activation, or use of a tenodesis grasp (wrist extension)
  • At least 6 months post injury
  • Participants do NOT have to stop taking antispasticity medications to participate in the study.
  • Must be tested for anemia with a value of at least 10g/dl (for both men and women).
  • Patients will be recommended to their primary care physician to correct anemia if low levels are detected
  • Blood pressure must fall within this range- high: 160/110mmHg low: 85/55 mmHg
  • Must be asymptomatic (no dizziness, lightheadedness, etc)

Exclusion criteria

  • Medical conditions, including: congestive heart failure, cardiac arrhythmias, uncontrolled hypertension, uncontrolled diabetes mellitus, chronic obstructive pulmonary disease, emphysema, severe asthma, previous myocardial infraction, or known carotid/intracerebral artery stenosis.
  • Women who are currently pregnant or planning on becoming pregnant
  • Current tracheostomy placement
  • Utilization of mechanical ventilator for breathing
  • Current diagnosis of obstructive sleep apnea
  • Orthopedic injuries or surgeries that would limit participation
  • Concurrent participation in another research study or therapy services
  • Comorbid traumatic brain injury or other neurologic injuries that would impact cognition

Treatment and study plan

Upper extremity training/Armeo Spring

Combination Product

Armeo Spring is a gravity support system based on an ergonomic arm exoskeleton with integrated springs.

Primary outcomes

  1. GRASSP

    Time frame: 4 weeks

    Graded Redefined Assessment of Strength, Sensation and Prehension

Secondary outcomes

  1. 9-hole peg test

    Time frame: 4 weeks

    coordination

  2. grip strength

    Time frame: 4 weeks

    hand strength

Sponsors and collaborators

Lead sponsor

Shirley Ryan AbilityLab

Other

Collaborators

  • Congressionally Directed Medical Research Programs

Registry information

Important dates

Study start
2018
Primary completion
2023
Study completion
2025
First posted
Aug 23, 2018
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.